BONDRONAT 50 MG TABLET
By Bondronat
Rx
7 Tablet in a Strip

Composition
Ibandronic Acid(50mg)

Manufacturer - Roche Products India Pvt Ltd
1503, 15th Floor, 'The Capital', Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Expires on or after
October, 2025

liver
BONDRONAT 50 MG TABLET is considered safe for use in patients with liver disease. The available data indicates that adjusting the dose of BONDRONAT 50 MG TABLET may not be necessary for these patients. It is important to consult your doctor for guidance on using this medication if you have any liver issues.

kidney
BONDRONAT 50 MG TABLET is safe for use in patients with kidney disease, with no dose adjustment required. However, it is not recommended for those with severe renal impairment. Consult with your doctor for proper guidance before using BONDRONAT 50 MG TABLET.

alcohol
When taking BONDRONAT 50 MG TABLET, carefulness is recommended when drinking alcohol. It is important to talk to your doctor in such situations.

driving
BONDRONAT 50 MG TABLET typically does not impact driving ability.

pregnancy
BONDRONAT 50 MG TABLET is considered unsafe during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess the risks and benefits before recommending this medication. Please consult your doctor before using BONDRONAT 50 MG TABLET during pregnancy.

breastfeeding
It is better to consult your doctor before using BONDRONAT 50 MG TABLET during breastfeeding.
Habit Forming | No |
Chemical Class | Bisphosphonate Derivative |
Therapeutic Class | PAIN ANALGESICS |
Action Class | Bone resorption inhibitor -Bisphosphonates |
₹4030
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025